Humankind Investments LLC Moderna, Inc. Transaction History

Humankind Investments LLC

$400 Million
Q2 2025

A detailed history of Humankind Investments LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 10,617 shares of MRNA stock, worth $281,987. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,617

Previous 15,606 31.97%

Holding current value

$281,987

Previous $442,000 33.94%

% of portfolio

0.07%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	SELL	$23.65 - $28.54 $117,989 - $142,386	-4,989 Reduced 31.97%	10,617 $292,000
Q1 2025 May 14, 2025	BUY	$28.35 - $47.53 $33,424 - $56,037	1,179 Added 8.17%	15,606 $442,000
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $318,310 - $552,227	8,638 Added 149.21%	14,427 $599,000
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $140,389 - $276,058	2,206 Added 61.57%	5,789 $386,000
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $348,162 - $573,138	-3,440 Reduced 48.98%	3,583 $425,000
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $52,331 - $70,764	-613 Reduced 8.03%	7,023 $748,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $130,817 - $196,537	1,882 Added 32.71%	7,636 $759,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $101,712 - $133,573	1,055 Added 22.45%	5,754 $594,000
Q2 2023 Aug 18, 2023	SELL	$118.5 - $160.53 $202,279 - $274,024	-1,707 Reduced 26.65%	4,699 $570,000
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $502,440 - $680,647	4,240 Added 195.75%	6,406 $778,000
Q1 2023 Apr 25, 2023	BUY	$135.66 - $197.02 $29,166 - $42,359	215 Added 11.02%	2,166 $332,000
Q4 2022 Jan 26, 2023	SELL	$118.38 - $210.04 $58,124 - $103,129	-491 Reduced 20.11%	1,951 $0
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $25,503 - $41,942	216 Added 9.7%	2,442 $289,000
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $3,865 - $5,827	-33 Reduced 1.46%	2,226 $318,000
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $136,703 - $254,089	1,081 Added 91.77%	2,259 $389,000
Q4 2021 Mar 21, 2022	BUY	$225.82 - $368.51 $98,909 - $161,407	438 Added 59.19%	1,178 $299,000
Q3 2021 Mar 21, 2022	SELL	$221.9 - $484.47 $74,558 - $162,781	-336 Reduced 31.23%	740 $285,000
Q2 2021 Mar 21, 2022	BUY	$129.91 - $234.98 $139,783 - $252,838	1,076 New	1,076 $253,000

Others Institutions Holding MRNA

# of Institutions

862

Shares Held

267M

Call Options Held

28.5M

Put Options Held

34.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.

Account

Humankind Investments LLC Moderna, Inc. Transaction History